论文信息 - Raltegravir Versus Efavirenz Regimens in Treatment-Naive HIV-1–Infected Patients: 96-Week Efficacy, Durability, Subgroup, Safety, and Metabolic Analyses - 字舞流文

Raltegravir Versus Efavirenz Regimens in Treatment-Naive HIV-1–Infected Patients: 96-Week Efficacy, Durability, Subgroup, Safety, and Metabolic Analyses

A. Lazzarin | Jinrong Zhao | R. Leavitt | H. Teppler | R. Pollard | A. Rodgers | D. Berger | B. Nguyen | J. Lennox | E. Dejesus | M. Dinubile | Richard J. O. Barnard | P. Sklar | H. Wan | M. Miller | C. Gilbert | José Valdez Ramalho Madruga | Michael D. Miller